Table 1.
Baseline characteristics of study participants by intervention group for complete case analysis. Values are numbers (percentages) unless stated otherwise
| Characteristics | Atosiban (n=410) | Fenoterol (n=408) |
|---|---|---|
| Mean (SD) age (years) | 32.1 (4.0) | 32.4 (4.3) |
| Multiparous women | 154 (38) | 153 (37) |
| Mean (SD) gestational age at ECV (weeks) | 35.8 (0.9) | 35.9 (1.0) |
| White ethnicity | 350 (85.4) | 355 (87.0) |
| Mean (SD) body mass index | 24.1 (4.3) | 24.2 (4.8) |
| Mean (SD) estimated fetal weight (g)* | 2622 (391.0) | 2572 (457.5) |
| Frank breech presentation† | 300 (76) | 273 (70) |
| Anterior placenta‡ | 127 (33) | 144 (37) |
| Mean (SD) estimated amniotic fluid index§ | 13.8 (4.9) | 13.7 (4.7) |
ECV=external cephalic version.
*Missing data: n=234 for atosiban, n=250 for fenoterol.
†Missing data: n=392 for atosiban, n=391 for fenoterol.
‡Missing data: n=386 for atosiban, n=386 for fenoterol.
§Missing data: n=263 for atosiban, n=281 for fenoterol.